Unknown

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

B-PaLMZ for TB Meningitis

Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

SEARCH SAPPHIRE Phase B

Trial Phase: Syndemic Adapted Medly Uganda

A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

Alternative Dosing And Prevention of Transfusions (ADAPT)

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

An International Observational Study of Adults With Acute Infection

Shortened Regimen for Drug-susceptible TB in Children

Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda